Tag: Orally disintegrating tablet

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Orally disintegrating tablet

Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of ...

Added to Collection on: 2024-03-29 20:28:13

Tags for this article:

Collagen disease
enzastaurin
Piperidines
Ehlers–Danlos syndrome
Ehlers
Orally disintegrating tablet
Aytu BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on ...

Added to Collection on: 2024-05-08 21:20:05

Tags for this article:

Dosage forms
Anorectics
Attention deficit hyperactivity disorder management
Ergogenic aids
TAAR1 agonists
Orally disintegrating tablet
Tablet
Amphetamine
Medical prescription
Fluoride
ODT
Aytu BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Added to Collection on: 2024-08-08 21:44:06

Tags for this article:

Dosage forms
Anorectics
Attention deficit hyperactivity disorder management
Ergogenic aids
TAAR1 agonists
Orally disintegrating tablet
Tablet
Amphetamine
ODT
Aytu BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to ... - BioSpace

Added to Collection on: 2024-10-01 21:06:33

Tags for this article:

Amphetamine
Attention deficit hyperactivity disorder management
Nootropics
Stimulants
Ergogenic aids
Management of attention deficit hyperactivity disorder
Orally disintegrating tablet
Attention deficit hyperactivity disorder
Methylphenidate
Adderall
Lupin Limited
Tablet
Aytu BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to ... - Quantisnow

Added to Collection on: 2024-10-01 18:49:19

Tags for this article:

Amphetamine
Attention deficit hyperactivity disorder management
Nootropics
Stimulants
Ergogenic aids
Management of attention deficit hyperactivity disorder
Orally disintegrating tablet
Methylphenidate
Attention deficit hyperactivity disorder
Adderall
Lupin Limited
Tablet
Aytu BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Wilson Sonsini Advises Aytu BioPharma in Exclusive Agreement with Lupin Pharma Canada Ltd

Added to Collection on: 2024-10-03 23:41:12

Tags for this article:

Stimulants
Attention deficit hyperactivity disorder management
Nootropics
Wakefulness-promoting agents
Euphoriants
Orally disintegrating tablet
Amphetamine
Attention deficit hyperactivity disorder
Adderall
Methylphenidate
ODT
Pemoline
Lupin Pharma Canada Ltd
wilson sonsini
Aytu BioPharma Inc.
Lupin Limited

Click the tags to see associated articles and topics

View Article Details
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on ...

Added to Collection on: 2024-11-06 22:31:04

Tags for this article:

Dosage forms
Food and Drug Administration
Attention deficit hyperactivity disorder management
Ergogenic aids
TAAR1 agonists
Orally disintegrating tablet
Fluoride
Tablet
Amphetamine
ODT
Medical prescription
Boxed warning
Aytu BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results ...

Added to Collection on: 2025-02-05 23:13:43

Tags for this article:

Dosage forms
Food and Drug Administration
Orally disintegrating tablet
Attention deficit hyperactivity disorder management
Ergogenic aids
TAAR1 agonists
Tablet
Amphetamine
ODT
XR
Medical prescription
Fluoride
Aytu BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Added to Collection on: 2025-04-21 21:15:47

Tags for this article:

Dosage forms
Anorectics
Attention deficit hyperactivity disorder management
Ergogenic aids
TAAR1 agonists
Orally disintegrating tablet
Tablet
Amphetamine
ODT
XR
Aytu BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and ...

Added to Collection on: 2025-09-17 02:09:07

Tags for this article:

Dosage forms
Anorectics
Attention deficit hyperactivity disorder management
Ergogenic aids
TAAR1 agonists
Orally disintegrating tablet
Tablet
Amphetamine
ODT
Aytu BioPharma Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo